SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001841099-21-000003
Filing Date
2021-04-28
Accepted
2021-04-28 11:20:15
Documents
1
Effectiveness Date
2021-04-28
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7979
  Complete submission text file 0001841099-21-000003.txt   9043
Mailing Address 5070 N. 40TH STREET SUITE 220 PHOENIX AZ 85018
Business Address 5070 N. 40TH STREET SUITE 220 PHOENIX AZ 85018 617-223-1585
CND Life Sciences, Inc. (Filer) CIK: 0001841099 (see all company filings)

IRS No.: 821795059 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-386767 | Film No.: 21862539